AI News NQ Analysis

【Syngen Biotech】February 2026 Revenue: 0.03 Billion (YoY +186.2%)

NQ Score 63/100
N1 Content Completeness 4

AI Summary (NQ-processed)

Syngen Biotech (6794) has released its financial report for February 2026. The company's revenue for the month was 2,630 thousand NTD (0.03 billion NTD), an increase of 186.2% compared to the same period last year. Syngen Biotech is a company specializing in the biotechnology and healthcare industry.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What was Syngen Biotech's revenue for February 2026?
A: Syngen Biotech's revenue for February 2026 was 0.03 billion NTD, which is equivalent to 2,630 thousand NTD.
Q: How did Syngen Biotech's revenue in February 2026 compare to the previous year?
A: Syngen Biotech's revenue in February 2026 showed a significant year-over-year increase of 186.2%.
Q: What is the company code for Syngen Biotech?
A: The company code for Syngen Biotech is 6794.
Q: In which industry sector does Syngen Biotech operate?
A: Syngen Biotech operates within the Biotechnology & Medical Care industry sector.
Q: What was the exact monthly revenue figure for Syngen Biotech in February 2026?
A: The exact monthly revenue figure for Syngen Biotech in February 2026 was 2,630 thousand NTD.